Compass Therapeutics (CMPX) Amortizatization of Intangibles (2021 - 2026)
Powered by 
Analysis
Compass Therapeutics (CMPX) Amortizatization of Intangibles (2021 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.74 Bn | 130.89 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.52 Bn | 77.52 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 63.51 Bn | 58.32 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.04 Bn | 52.91 Bn | 52.00 Mn | - |
| 5 | Revolution Medicines | 44.06 Bn | 44.06 Bn | - | 4.33 Mn |
| 6 | BeOne Medicines | 39.98 Bn | 34.88 Bn | 1.53 Bn | - |
| 7 | Alnylam Pharmaceuticals | 35.46 Bn | 32.15 Bn | 992.69 Mn | - |
| 8 | Royalty Pharma | 28.41 Bn | 27.57 Bn | - | - |
| 9 | Insmed | 27.44 Bn | 26.28 Bn | 358.27 Mn | 678,000.00 |
| 10 | Compass Therapeutics | 443.65 Mn | 443.65 Mn | - | 355,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 355,000.00 |
| Mar 31, 2026 | 353,000.00 |
| Dec 31, 2025 | 353,000.00 |
| Sep 30, 2025 | 352,000.00 |
| Jun 30, 2025 | 267,000.00 |
| Mar 31, 2025 | 224,000.00 |
| Dec 31, 2024 | 219,000.00 |
| Sep 30, 2024 | 322,000.00 |
| Jun 30, 2024 | 314,000.00 |
| Mar 31, 2024 | 309,000.00 |
| Dec 31, 2023 | 307,000.00 |
| Sep 30, 2023 | 302,000.00 |
| Jun 30, 2023 | 295,000.00 |
| Mar 31, 2023 | 287,000.00 |
| Dec 31, 2022 | 289,000.00 |
| Sep 30, 2022 | 285,000.00 |
| Jun 30, 2022 | 278,000.00 |
| Mar 31, 2022 | 270,000.00 |
| Dec 31, 2021 | 272,000.00 |
| Sep 30, 2021 | 268,000.00 |